These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16385656)

  • 41. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract.
    Choi D; Lim HK; Kim MJ; Kim SH; Lee WJ; Kim SH; Lim JH; Paik SW; Koh KC; Yoo BC
    AJR Am J Roentgenol; 2004 Nov; 183(5):1417-24. PubMed ID: 15505314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
    Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous ethanol injection for hepatocellular carcinoma originating in the caudate lobe.
    Shibata T; Kubo S; Tabuchi T; Maetani Y; Ametani F; Itoh K; Konishi J
    Hepatogastroenterology; 2000; 47(33):824-7. PubMed ID: 10919039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
    Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.
    Bernal P; Raoul JL; Vidmar G; Sereegotov E; Sundram FX; Kumar A; Jeong JM; Pusuwan P; Divgi C; Zanzonico P; Stare J; Buscombe J; Minh CT; Saw MM; Chen S; Ogbac R; Padhy AK
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1448-55. PubMed ID: 17692473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy.
    McStay MK; Maudgil D; Williams M; Tibballs JM; Watkinson AF; Caplin ME; Buscombe JR
    Radiology; 2005 Nov; 237(2):718-26. PubMed ID: 16192318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. External beam radiotherapy to treat intra- and extra-hepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation.
    Yamashita H; Nakagawa K; Shiraishi K; Tago M; Igaki H; Nakamura N; Sasano N; Shiina S; Omata M; Ohtomo K
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1555-60. PubMed ID: 16928216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma.
    Chen SW; Lin LC; Kuo YC; Liang JA; Kuo CC; Chiou JF
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1041-7. PubMed ID: 24661657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities.
    Lim DH; Lee H; Park HC; Lee JA; Kim SW; Yoo BC; Koh KC; Lee JH; Choi MS; Gwak GY; Paik SW
    Am J Clin Oncol; 2013 Apr; 36(2):162-6. PubMed ID: 22391433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
    Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasound guided percutaneous ethanol injection of hepatocellular carcinoma.
    Spârchez Z; Bolog N
    Rom J Gastroenterol; 2003 Jun; 12(2):147-55. PubMed ID: 12854004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
    Lewandowski RJ; Riaz A; Ryu RK; Mulcahy MF; Sato KT; Kulik LM; Gates VL; Baker T; Omary R; Salem R
    J Vasc Interv Radiol; 2009 Dec; 20(12):1557-63. PubMed ID: 19854068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.
    Llovet JM; Vilana R; Brú C; Bianchi L; Salmeron JM; Boix L; Ganau S; Sala M; Pagès M; Ayuso C; Solé M; Rodés J; Bruix J;
    Hepatology; 2001 May; 33(5):1124-9. PubMed ID: 11343240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow.
    de Baere T; Taourel P; Tubiana JM; Kuoch V; Ducreux M; Lumbroso J; Roche AJ
    Radiology; 1999 Sep; 212(3):665-8. PubMed ID: 10478229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial.
    Mornex F; Girard N; Beziat C; Kubas A; Khodri M; Trepo C; Merle P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1152-8. PubMed ID: 17145534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma.
    Giorgio A; Tarantino L; de Stefano G; Scala V; Liorre G; Scarano F; Perrotta A; Farella N; Aloisio V; Mariniello N; Coppola C; Francica G; Ferraioli G
    AJR Am J Roentgenol; 2003 Aug; 181(2):479-84. PubMed ID: 12876030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatocellular carcinoma treated by percutaneous hot saline injection.
    Araki Y; Hukano M; Urabe M; Tsujikawa T; Yoshioka U; Inoue H; Hujiyama Y; Bamba T
    Oncol Rep; 2004 Sep; 12(3):569-71. PubMed ID: 15289839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local radiotherapy for patients with unresectable hepatocellular carcinoma.
    Park W; Lim DH; Paik SW; Koh KC; Choi MS; Park CK; Yoo BC; Lee JE; Kang MK; Park YJ; Nam HR; Ahn YC; Huh SJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1143-50. PubMed ID: 15752895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.